Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.54 |
| ▸ | HTRA2 | O43464 | 8/20 | 0.54 |
| ▸ | HTRA1 | Q92743 | 8/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.47 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906261 | 0.91 | ALB (0.52) | ALBHTRA2HTRA1FOLH1SLC5A2 | |
| SCHEMBL9906226 | 0.88 | ALB (0.49) | ALBHTRA2HTRA1FOLH1DNASE1L3 | |
| SCHEMBL9906321 | 0.87 | FOLH1 (0.55) | ALBHTRA2HTRA1FOLH1SLC5A2 | |
| SCHEMBL9906192 | 0.87 | ALB (0.49) | ALBHTRA2HTRA1FOLH1SLC5A2 | |
| SCHEMBL9906325 | 0.86 | FOLH1 (0.54) | ALBHTRA2HTRA1FOLH1SLC5A2 | |
| SCHEMBL9906229 | 0.85 | FOLH1 (0.51) | ALBHTRA2HTRA1FOLH1DNASE1L3 | |
| SCHEMBL12123525 | 0.85 | ALB (0.60) | ALBHTRA2HTRA1FOLH1SLC5A2 | |
| SCHEMBL12675193 | 0.84 | ALB (0.58) | ALBHTRA2HTRA1FOLH1DNASE1L3 | |
| SCHEMBL24062674 | 0.84 | ALB (0.59) | ALBHTRA2HTRA1FOLH1DNASE1L3 | |
| SCHEMBL18211595 | 0.84 | ALB (0.59) | ALBHTRA2HTRA1FOLH1DNASE1L3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034798-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2015-05-19 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100248264-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | ALB 60/4885HTRA2 1592/4885HTRA1 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.